Even in year one, analysts expect orforglipron to reach $500 million in sales and serve 360,000 patients, helping the three-drug franchise deliver $25.7 billion in 2026 alone
Results Overall and sex-specific associations of genetically predicted l-carnitine with CVD Genetically predicted higher l-carnitine was nominally associated with higher risk of CAD and heart failure in men and women, with odds ratio (OR) 1.07 (95% confidence interval (CI) 1.02 to 1.11) for CAD and OR 1.05 (95% CI 1.01 to 1.09) for heart failure per standard deviation (SD) increase in genetically predicted l-carnitine (Fig
Although that may not seem like a lot, it translates to about 7.6 million fewer adults with obesity
A BMI of 30 qualifies under Tier 2 with one of three specific conditions
The findings were groundbreaking: at the 6-month mark, subjects taking the 1,000 mg daily dose experienced a 30% to 35% increase in glutathione levels within their erythrocytes (red blood cells), plasma, and lymphocytes